Public datasets primarily show successful protein interactions, starving AI models of crucial "negative data"—plausible but incorrect interactions. A-Alpha Bio finds that providing this data on what fails is just as important for training predictive and generalizable models.

Public internet data has been largely exhausted for training AI models. The real competitive advantage and source for next-generation, specialized AI will be the vast, untapped reservoirs of proprietary data locked inside corporations, like R&D data from pharmaceutical or semiconductor companies.

Moonwalk enhances a commercial large language model by training it on their vast internal datasets of genetic, epigenetic, and siRNA screening results. This transforms the general AI into a specialized expert that can prioritize drug targets and generate unique biological insights, creating a significant competitive advantage.

Foundation models can't be trained for physics using existing literature because the data is too noisy and lacks published negative results. A physical lab is needed to generate clean data and capture the learning signal from failed experiments, which is a core thesis for Periodic Labs.

To break the data bottleneck in AI protein engineering, companies now generate massive synthetic datasets. By creating novel "synthetic epitopes" and measuring their binding, they can produce thousands of validated positive and negative training examples in a single experiment, massively accelerating model development.

Despite competitors raising billions of dollars in the AI drug discovery sector, massive capital alone does not guarantee superior models. Many well-funded firms rely on retraining algorithms using the same publicly available crystal structure data. Generating unique, specialized experimental data at scale allows a lean startup to build more accurate predictive models while consuming a fraction of the funding.

Scientific literature suffers from severe publication bias because researchers rarely publish failed syntheses. Models trained only on published successes lack negative controls and cannot master real-world exploration. Periodic Labs captures complete campaign histories—tracking failures, reasoning traces, and iterative adjustments. Liam Fedus argues that models must be trained on the messy process of conducting science rather than just final polished outputs.

The internet is an insufficient training ground for scientific AI because most crucial information—including failed experiments, negative data, and nuanced procedural details—is never published. This undocumented knowledge, what scientists call "good hands," represents a major data bottleneck for building truly intelligent scientific models.

The key advantage for AI biotech isn't the model itself, but generating massive, proprietary datasets ("science tokens") via automated labs. This novel data, which doesn't exist publicly, is crucial for training superior models and achieving true scientific intelligence.